👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
All content for Inside Lyme Podcast with Dr. Daniel Cameron is the property of Dr. Daniel Cameron and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
The likely reason for relapse is failure to eradicate the spirochete
Inside Lyme Podcast with Dr. Daniel Cameron
4 minutes
1 year ago
The likely reason for relapse is failure to eradicate the spirochete
The likely reason for relapse is failure to eradicate the spirochete completely with a two-week course of intravenous ceftriaxone therapy,” wrote Drs. Logigian, Kaplan, and Steere in their seminal 1990 paper on chronic neurologic Lyme disease. This observation remains as relevant today as it was over three decades ago, highlighting a persistent challenge in the treatment of Lyme disease: the difficulty in fully eliminating the Borrelia burgdorferi bacterium, which can lead to relapse or persi...
Inside Lyme Podcast with Dr. Daniel Cameron
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
